Skip to content

Sphenopalatine Ganglion Block and Pain Management in Neurosurgery

Sphenopalatine Ganglion Block and Pain Management in Neurosurgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05136625
Acronym
SpheNoPain
Enrollment
84
Registered
2021-11-29
Start date
2021-02-01
Completion date
2024-06-30
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Craniofacial Pain, Post Operative Pain

Keywords

sphenopalatine ganglion block, post-craniotomy pain

Brief summary

Post craniotomy pain is defined as headache developed up to 7 days from a craniotomy, not otherwise explained. A moderate to severe pain affects from 60 to 84% of patients. Sphenopalatine ganglion block has been successfully used in patients with chronic or acute headache, facial pain and for transsphenoidal pituitary and endoscopic sinus surgeries. There are evidences that sphenopalatine ganglion block reduces vegetative responses to skull pin closure. This study aim to investigate feasibility and efficacy of sphenopalatine ganglion block in reducing pain after a neurosurgical supratentorial craniotomy.

Interventions

DRUGSphenopalatine ganglion block

A cotton swab soaked in levobupivacaine 7,5% in inserted into the nose to block sphenopalatine ganglion, with the classic technique previously described

Troncular scalp blockade. Local site infiltration

Sponsors

University Hospital of Ferrara
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* supratentorial craniotomy

Exclusion criteria

* prior craniofacial pain syndrome * drug assumption: pain-killers (chronic), antiepileptic

Design outcomes

Primary

MeasureTime frameDescription
Numerical Rating ScaleImmediately post-opFrom 0 (no pain) to 10 (worst pain ever)
Visual Analogic ScaleImmediately post-opFrom 0 (no pain) to 10 (worst pain ever)
Pain Assessment IN Advanced DementiaImmediately post-opFrom 0 (no signs of pain) to 10 (Extreme pain)

Secondary

MeasureTime frameDescription
Adverse effectImmediately post-op, 1°-2°-3°-4°-30°-60°180° days post-opBitter taste, nose bleeding, throat discomfort
Vegetative response (Heart rate)1-5-10 min from skull pin closure. 1-5-10 min from skin incisionHeart rate in beat per minute
Vegetative response (Arterial pressure)1-5-10 min from skull pin closure. 1-5-10 min from skin incisionMean arterial pressure in mmHg

Countries

Italy

Contacts

Primary ContactAlba Scerrati, MD
scrlba@unife.it3381402733
Backup ContactGiorgio Mantovani, MD
mntgrg@unife.it3491974608

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026